BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

28 related articles for article (PubMed ID: 38488001)

  • 1. Meningioma achieves malignancy and erastin-induced ferroptosis resistance through FOXM1-AURKA-NRF2 axis.
    Ye Y; Xu L; Zhang L; Zhao P; Cai W; Fu G; Wang T; Tao Z; Shi W; Gu W; Hu J; Yuan G; Wei Y; Xu K; Bao Z; Chao H; Liu N; Zhao L; Tu Y; Ji J
    Redox Biol; 2024 Jun; 72():103137. PubMed ID: 38642502
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Keap1-Nrf2 Pathway Regulates ALDH and Contributes to Radioresistance in Breast Cancer Stem Cells.
    Kamble D; Mahajan M; Dhat R; Sitasawad S
    Cells; 2021 Jan; 10(1):. PubMed ID: 33419140
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nrf2 inhibition reverses the resistance of cisplatin-resistant head and neck cancer cells to artesunate-induced ferroptosis.
    Roh JL; Kim EH; Jang H; Shin D
    Redox Biol; 2017 Apr; 11():254-262. PubMed ID: 28012440
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nrf2 inhibition reverses resistance to GPX4 inhibitor-induced ferroptosis in head and neck cancer.
    Shin D; Kim EH; Lee J; Roh JL
    Free Radic Biol Med; 2018 Dec; 129():454-462. PubMed ID: 30339884
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isoflavone biochanin A, a novel nuclear factor erythroid 2-related factor 2 (Nrf2)-antioxidant response element activator, protects against oxidative damage in HepG2 cells.
    Liang F; Cao W; Huang Y; Fang Y; Cheng Y; Pan S; Xu X
    Biofactors; 2019 Jul; 45(4):563-574. PubMed ID: 31131946
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hydrogen sulfide protects retinal pigment epithelium cells against ferroptosis through the AMPK- and p62-dependent non-canonical NRF2-KEAP1 pathway.
    Yu M; Wang W; Dang J; Liu B; Xu J; Li J; Liu Y; He L; Ying Y; Cai J; Cheng G; Liu K
    Exp Cell Res; 2023 Jan; 422(1):113436. PubMed ID: 36435220
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ZMYND8 protects breast cancer stem cells against oxidative stress and ferroptosis through activation of NRF2.
    Luo M; Bao L; Xue Y; Zhu M; Kumar A; Xing C; Wang JE; Wang Y; Luo W
    J Clin Invest; 2024 Jan; 134(6):. PubMed ID: 38488001
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Panaxatriol saponin ameliorates myocardial infarction-induced cardiac fibrosis by targeting Keap1/Nrf2 to regulate oxidative stress and inhibit cardiac-fibroblast activation and proliferation.
    Yao H; He Q; Huang C; Wei S; Gong Y; Li X; Liu W; Xu Z; Wu H; Zheng C; Gao Y
    Free Radic Biol Med; 2022 Sep; 190():264-275. PubMed ID: 35977659
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of Nrf2 and PPARgamma in the improvement of oxidative stress in hypertension and cardiovascular diseases.
    Dovinova I; Kvandová M; Balis P; Gresova L; Majzunova M; Horakova L; Chan JY; Barancik M
    Physiol Res; 2020 Dec; 69(Suppl 4):S541-S553. PubMed ID: 33656904
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Xiaojianzhong decoction attenuates gastric mucosal injury by activating the p62/Keap1/Nrf2 signaling pathway to inhibit ferroptosis.
    Chen J; Zhang J; Chen T; Bao S; Li J; Wei H; Hu X; Liang Y; Liu F; Yan S
    Biomed Pharmacother; 2022 Nov; 155():113631. PubMed ID: 36122518
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Kelch-like ech-associated protein 1/nuclear factor E2-related factor 2/antioxidant response element pathway alleviates ferroptosis in sepsis by regulating oxidative stress].
    Li J; Wang H
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2021 Jul; 33(7):881-884. PubMed ID: 34412763
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nrf2 and oxidative stress in liver ischemia/reperfusion injury.
    G Bardallo R; Panisello-Roselló A; Sanchez-Nuno S; Alva N; Roselló-Catafau J; Carbonell T
    FEBS J; 2022 Sep; 289(18):5463-5479. PubMed ID: 34967991
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.